On July 29th, 2065438+0/KLOC-0, under the joint preparation of Qinghai Charity Federation, Jiangsu Charity Federation and Voice, the donation ceremony of "Let Love Continue" was held in front of the temporary board house school building built by Yushu Orphan School after the earthquake. The Simce Lei condolence group led by Ms. Gao Feifei, secretary of Simce Lei Party Committee, came to the children with gifts. Mao, Deputy Secretary General of Jiangsu Charity Federation, Ma Shengbao, Deputy Secretary General of Qinghai Charity Federation, Deputy Director of Yushu Civil Affairs Bureau, and Qing Meiduojie, Director of Yushu Education Bureau also came to the scene to witness this warm moment. Qinghai TV station was also present for an interview. At the donation ceremony, the voice donated100,000 yuan school grants, 55,000 yuan worth of medicines and 20,000 yuan worth of books donated by Jiangsu Charity Federation to the children. In addition, every orphan student who was helped to raise a child got a beautiful gift to support himself. School/KLOC-More than 0/00 unsupported students also received a fresh gift-a can of candy. The children were in high spirits with gifts, dressed in colorful costumes, singing and dancing. Although the summer climate is sultry, they still have bright smiles on their faces, so they should dedicate the most beautiful dances and songs to those who love them. At this moment, people seem to have almost forgotten the heavy blow of fate to themselves.
Seeing the children's lovely faces, simple classrooms and hard living conditions, many employees of Pioneer have helped raise more than a dozen orphans. First Voice employees have donated more than 60 orphans. Every child will receive a subsidy of 1 100 yuan every year until adulthood. 20 1 1 After the donation ceremony of Yushu Orphan School, the grandfather's love continued. The story of Mr. Yu Shuhe continues. 20 1 1 On June 24th, the "201China Hospital Dean's High-level Forum and Public Hospital Reform Symposium" co-sponsored by China Hospital Association, Ministry of Health, People's Daily, Shanxi Provincial Health Department and Taiyuan Municipal People's Government was held in Taiyuan. More than 300 representatives from more than 70 hospitals and nearly 20 mainstream media including People's Daily and china national radio participated in the forum. Cao, president of China Hospital Association, spokesperson of the Ministry of Health, director of the news and publicity center, Sun Yang, deputy director of the medical administration department of the Ministry of Health, Gao Guoshun, director of the Shanxi Provincial Health Department, Bai Jianfeng, deputy mayor of Taiyuan, editor-in-chief of the Economic and Social Department of People's Daily, Dong, deputy editor-in-chief of People's Daily, Qian Haibo, secretary of the board of directors of the voice, and Feng Quanfu, vice president, attended the meeting.
This forum is divided into several topics, such as "integrating medical resources to facilitate people's medical treatment", "medical community and medical consortium model" and "breaking the cocoon into a butterfly-enterprise hospitals solve the development dilemma", and discusses how to solve the worldwide problem of medical reform with China method in many aspects. Gong Wenhua, director of the administrative center of the provincial Chang Gung Memorial Hospital, shared the theme of "Chang Gung Memorial Hospital Model", which was highly praised by the leaders and experts attending the meeting.
Vice President Feng Quanfu delivered a speech on behalf of the voice. He said that simcere was very happy to participate in hosting this high-level forum. As an undergraduate enterprise with dreams, pursuits, courage to explore and innovate, it is determined to "become the leader of innovative drug research and development in China" and is constantly forging ahead under the inspiration of this concept and national responsibility. In the future, Xiansheng will continue to adhere to this concept, strengthen communication with the government, medical system and the same industry, and jointly contribute to the development of health in China.
The holding of the president's high-level forum has created a good opportunity for government departments and the national hospital system to communicate in depth and seek common development, which is of positive significance to promoting the development of China's health cause. At the same time, by participating in this activity, simcere has strengthened in-depth exchanges with the Ministry of Health, Shanxi Provincial Health Department and other government departments, dozens of provincial first-line hospitals, People's Daily, People's Daily and other mainstream media, which has enhanced understanding and deepened friendship and laid a good foundation for further market cooperation in the future. On the morning of 2011August16th, the media meeting of "Merck shy" cooperation with Xiansheng Group was held in the conference center of Xiansheng Group headquarters. More than 20 domestic and foreign media from Beijing, Shanghai, Guangzhou and Nanjing were invited to attend the media meeting. Mr. Feng Naxi, Global Senior Vice President and President of Merck China; Mr. Wen Haoji, Financial Controller of Merck China; Ren Jinsheng and Zhang, Chairman of Voice, attended the meeting and answered questions from the media. At 4: 00 p.m. on July 2 1 U.S. time, Merck and Xiansheng Technology signed a cooperation agreement at Merck Laboratories in the United States. This is an innovative cooperative relationship, which will establish a joint venture company suitable for both parties' goals, and combine the R&D, registration, production and sales capabilities of both parties to provide more efficient and innovative medical products and services for patients in China. This cooperation has attracted extensive attention from many domestic and foreign medical and financial media. The background, significance and future goal of this cooperation became the focus of media questioning, which contributed to the convening of this media meeting. Within two hours, Global Entrepreneur, Health News, Science and Technology Daily, Pharmaceutical Manager and China Business Weekly asked questions about the integration of ideas in the cooperation between the two parties, the strategic goal of the newly established joint venture company, and the innovative significance of this cooperation. Merck and the high-level voice answered the media's concerns one by one. After the scheduled interview time ended, many media communicated with the top management of the two companies on other issues they were concerned about, and at the same time, the top management of both sides also accepted TV interviews with CCTV, Jiangsu Satellite TV and Nanjing TV.
Next, Merck and Simce Ray will communicate and discuss more problems about R&D and production. I believe this cooperation will be a brand-new beginning and will bring health protection to more patients. The second national congress of China Hospital Association, sponsored by China Hospital Association and co-organized by voice, was held in Beijing on August 7th, 201/kloc-0. Vice Minister of Health, Second President of China Hospital Association, Vice Minister of Health, Vice Minister of Health of PLA General Logistics Department, former Vice Minister of Health, First President and Second Honorary President of China Hospital Association, Cao, as well as leaders of Civil Affairs Bureau, General Office of Ministry of Health, International Department of Ministry of Health, Ministry of Health, Armed Police Headquarters, Chinese Medical Association, Hong Kong Food and Health Bureau, Hong Kong Department of Health, Macau Health Bureau and Taiwan Province Medical Management Association attended the meeting. The Second National Congress of China Hospital Association deliberated and adopted the work report made by President Cao on behalf of the first Council, and elected 393 directors and 132 standing directors of the second Council of China Hospital Association. Huang Jiefu, Vice Minister of Health, was elected as the second president of China Hospital Association. Li Hongshan was elected as the second secretary general of China Hospital Association.
The leaders present at the meeting presented commemorative cards to the first leaders of China Hospital Association and certificates to the elected second leaders. Huang Jiefu made a work report entitled "Serving the reform and development of hospitals to create a new situation in the work of the Association".
In the evening, at the welcome dinner of the voice held in the Great Hall of the People, Zhang, the president of the voice, toasted all the participants, warmly congratulated the successful establishment of the second Council of China Hospital Association, and paid tribute to the hard work of the first Council. President Zhang also briefly reported on several major achievements made in simcere, including the commissioning of the second phase of simcere Research Institute, the clinical application of a class of new drugs in five countries, and the signing of a cooperation framework agreement with Merck, a famous American pharmaceutical company. Xiansheng hopes and is willing to continue to promote the development of health in China through continuous cooperation with China Hospital Association, so as to benefit more patients. On August 24th, 20 1 1, the voice announced that its new drug, Aidixin (Elamod tablets), which was independently developed by itself, had officially obtained the first-class national certificate for new drugs and the drug registration approval of China State Food and Drug Administration (SFDA).
Mr. Ren Jinsheng, Chairman of Voice, said: "The listing of Aidixin, a national first-class new drug, will give millions of patients who have been troubled by rheumatoid arthritis for a long time in China the opportunity of higher quality treatment, so the listing of Aidixin, a first-class new drug, is also a major breakthrough for Voice on the road of drug innovation."
In order to further strengthen disease classification management, evaluate the quality of diagnosis and treatment of rheumatism, and improve the level of diagnosis and treatment of rheumatism in China, the National Data Center for Diagnosis and Treatment of Rheumatism (CRIS Center for short) was established in Beijing on 201165438+1October 27th. Leaders of the Department of Medical Management of the Ministry of Health, members of the Rheumatology Branch of the Chinese Medical Association and 142 professional rheumatologists from all over the country attended the kick-off meeting of the CRIS Center. At the kick-off meeting of CRIS Center, Simcere held a satellite meeting of Aidixin, a new national rheumatoid drug. The satellite conference was presided over by Professor Zeng Xiaofeng, Chairman-designate of China Rheumatology Branch. At the meeting, Professor Li Xiaofeng from the Second Affiliated Hospital of Shanxi Medical University made a full discussion on the time to market, product information, advantages, etc. Through this satellite meeting, experts from the Department of Rheumatology of the National 142 Key Hospital clearly and in detail learned the news of the upcoming listing of Adelson and the information of its core products. At the same time, simcere took this opportunity to establish a good communication and cooperation mechanism with rheumatologists all over the country, which laid a very important foundation for Aidexin, which will be listed in the whole country. 2065438+02108 12 simcere held a press conference on the industrialization achievements of Elamod, a major scientific and technological special support project of "major new drug creation", and officially announced the list of REG, the world's first small molecule drug for treating rheumatoid arthritis.
The meeting was presided over by Rui Chenggang, a famous mouth of CCTV. Professor Li, Chairman of Rheumatology Branch of Chinese Medical Association, Professor Bao Chunde, Vice Chairman of Rheumatology Branch of Chinese Medical Association, Academician of China Academy of Engineering, Professor Liu Changxiao, Researcher of Tianjin Institute of Medicine, and Li Zhengqing, President of China District of Merck attended the meeting and delivered speeches respectively. Professor Li introduced the current situation and limitations of drugs for treating rheumatoid diseases to rheumatologists from all over the country and journalists from more than 40 famous public or medical and financial media in China. Professor Bao Chunde introduced the mechanism of Addison & reg and the results of clinical research.
Subsequently, Professor Li and Professor Bao Chunde also attended the press conference together with Ren Jinsheng, Chairman of Xiansheng Technology, and Yin Xiaojin, Senior Vice President, and answered questions from reporters. Dozens of reporters from the national media talked about Addison &; Reg gave detailed answers to enthusiastic questions about R&D process, medication plan, clinical value, possible future indications expansion, overseas expansion plan and so on.
Professor Li said: Addison developed; Reg is the first preparation of Elamod in the world and the first new anti-rheumatoid drug with independent intellectual property rights in China. Edison company. The successful development and marketing of the drug is of great significance to the treatment and control of rheumatic diseases, and it is an important milestone in the scientific research work of preventing and treating rheumatic diseases in China, which indicates that China has been in a leading position in the research and development of anti-rheumatic drugs.
Rheumatoid arthritis is one of the biggest diseases in the world. The main products in the world are used to treat symptoms, but there is still a lack of ideal drugs for small molecular autoimmune diseases. 20 1 1 August, Addison &; Reg China State Food and Drug Administration (SFDA) officially obtained the national first-class certificate of new drugs and the approval of drug registration, which really filled this gap. Treating the pathogenesis of rheumatoid arthritis will bring health protection to hundreds of millions of patients.